2. Gene
  3. C6 - complement C6 Gene

C6 - complement C6 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

基因 ID: 24237 | 基因类型: protein coding

关于 C6

功能概要

Involved in positive regulation of apoptotic process. Located in extracellular space. Used to study end stage renal disease; glomerulonephritis; and proteinuria. Human ortholog(s) of this gene implicated in Complement Component 6 deficiency. Orthologous to human C6 (complement C6). [provided by Alliance of Genome Resources, Apr 2022]

C6 基因产物(1)

mRNA Protein Name
NM_176074.4 NP_788263.2 complement component C6 precursor
基因本体论
  • 生物过程
  • 细胞组分
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in positive regulation of apoptotic process IMP
IMP: 通过突变表型推断
10807586 RGD
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in extracellular space IDA
IDA: 通过直接分析推断
8089494 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

complement component C6

complement component 6

相关产品

Approval
生物活性分子 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-N7140 Gamma-Linolenic acid Inhibitor 99.80% 否
Clinical Phase
生物活性分子 (4)
目录号 产品名 作用方式
纯度 Phase
HY-W747264 P-Hydroxybenzaldehyde-13C6 / Phase 4
HY-104036 IDH-305 Inhibitor 99.15% Phase 2
HY-N2037A Higenamine hydrochloride 99.52% Phase 1
HY-N2037 Higenamine 98.91% Phase 1
Pre-clinical Phase
生物活性分子 (722)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-B0389A D-Glucose-13C6 99.93% 否
HY-129047 Trypsin Activator 91.00% 否
HY-16594 Lactacystin 98.20% 否
HY-19542 C6 Ceramide Inducer 99.82% 否
HY-111997 VH285-PEG4-C4-Cl ≥98.0% 否
HY-N7264 7α-Hydroxycholesterol Inhibitor 99.99% 否
HY-D0180 18-Crown-6-ether 99.77% 否
HY-N0455AS8 L-Arginine-13C6,15N4 hydrochloride Activator 99.30% 否
HY-N1428S1 Citric acid-13C6 99.90% 否
HY-129047A Trypsin (MS grade) Activator 95.00% 否
HY-140921 Biotin-PEG4-amino-t-Bu-DADPS-C6-azide ≥95.0% 否
HY-100014 KDM5A-IN-1 Inhibitor 99.64% 否
HY-W011561 Boc-NH-C6-Br ≥98.0% 否
HY-N1127 Tricin Inhibitor 99.87% 否
HY-N7092S D-Fructose-13C6 99.95% 否
HY-107836 Methiothepin mesylate Antagonist 99.60% 否
HY-145442 8-Azanebularine Inhibitor 99.33% 否
HY-N0455AS6 L-Arginine-13C6 hydrochloride Activator 99.00% 否
HY-140914 Biotin-PEG4-Amide-C6-Azide 99.11% 否
HY-W008296 NH2-C6-NH-Boc 99.61% 否
HY-N0470S3 L-Lysine-13C6,15N2 hydrochloride Inhibitor ≥98.0% 否
HY-W356116 C6 NBD Ceramide 99.33% 否
HY-140314 DOTA-PEG5-C6-DBCO 96.27% 否
HY-N6974 Ascr#2 ≥98.0% 否
HY-111753A WDR5-IN-4 TFA 99.87% 否
HY-N0215S8 L-Phenylalanine-13C6 Antagonist 99.8% 否
HY-112495 VH032-PEG5-C6-Cl 99.93% 否
HY-N0486S8 L-Leucine-13C6,15N Activator 99.90% 否
HY-112537S1 D-Glucose 6-Phosphate-13C6 disodium xhydrate 99.6% 否
HY-W009762S L-Lysine-13C6,15N2 dihydrochloride 99.40% 否
HY-138470 Azido-PEG2-C6-Cl ≥95.0% 否
HY-139218 (S,R,S)-AHPC-Me-C6-NH2 99.81% 否
HY-B0322S1 Sulfamethoxazole-13C6 Inhibitor 99.80% 否
HY-133689AS 3-Nitrophenylhydrazine-13C6 hydrochloride 98.26% 否
HY-N0486S2 L-Leucine-13C6 Activator ≥98.0% 否
HY-129622A NH2-PEG5-C6-Cl hydrochloride ≥98.0% 否
HY-N0379S22 D-Mannose-13C6 ≥98.0% 否
HY-112496 Cl-C6-PEG4-O-CH2COOH ≥98.0% 否
HY-114165 DJ-V-159 Agonist 99.94% 否
HY-N0771S L-Isoleucine-13C6 ≥98.0% 否
HY-111253 CYM-5478 Agonist 99.90% 否
HY-N0210S16 D-Galactose-13C6 ≥99.0% 否
HY-W014375S2 Arginine-13C6 hydrochloride 99.00% 否
HY-W356117 C6 NBD Glucosylceramide ≥98.0% 否
HY-138521 Azido-C6-OH ≥95.0% 否
HY-N0473S2 L-Tyrosine-13C6 99.90% 否
HY-N2038 3,​5,​6,​7,​8,​3',​4'-​Heptemthoxyflavone Inhibitor 99.86% 否
HY-15330 Vitamin D2-d3 Activator 98.60% 否
HY-135250B Thalidomide-4-O-C6-NH2 hydrochloride Inducer 98.53% 否
HY-103605 (S,R,S)-AHPC-C6-PEG3-C4-Cl 97.01% 否
HY-138466 Azido-PEG3-C6-Cl 95.30% 否
HY-B0143S3 Niacin-13C6 Inducer 99.90% 否
HY-B0166S L-Ascorbic acid-13C6 99.90% 否
HY-121805 DBCO-​C6-​acid 97.52% 否
HY-138469 NH2-PEG3-C6-Cl ≥95.0% 否
HY-141576 C6-NBD Sphinganine ≥99.0% 否
HY-N6076 Tenuifoliside A Inhibitor 98.07% 否
HY-P3146S FTISADTSK-13C6,15N2 TFA 99.02% 否
HY-113248S1 3-Nitro-L-tyrosine-13C6 ≥95.0% 否
HY-119402 TP-021 Inhibitor 99.14% 否
HY-126683 Mal-C6-α-Amanitin 98.48% 否
HY-111753 WDR5-IN-4 98.13% 否
HY-161536 PROTAC EGFR degrader 9 98.35% 否
HY-B0389S D-Glucose-13C6,d7 ≥98.0% 否
HY-N0469S1 L-Lysine-13C6 dihydrochloride Inhibitor 98.70% 否
HY-130951 Thalidomide-O-C6-COOH Inducer 99.29% 否
HY-132004 Tos-O-C4-NH-Boc 97.03% 否
HY-155262 Pomalidomide-5-C6-NH2 hydrochloride 98.46% 否
HY-N0733S3 Glucosamine-6-13C hydrochloride ≥98.0% 否
HY-N2461 Ganoderic acid C6 99.40% 否
HY-18569S4 3-Indoleacetic acid-13C6 ≥98.0% 否
HY-B0252S2 Hydrochlorothiazide-13C6 99.61% 否
HY-B0400S16 D-Sorbitol-13C6 99.94% 否
HY-N0086S1 N6-Methyladenosine-13C 99.9% 否
HY-P1032S2 Angiotensin I-13C6,15N (human, mouse, rat) TFA 99.76% 否
HY-103608 (S,R,S)-AHPC-(C3-​PEG)​2-​C6-​Cl 99.89% 否
HY-131089 MC-VC-PABC-C6-α-Amanitin 98.88% 否
HY-136006B (S,R,S)-AHPC-C6-NH2 98.03% 否
HY-137905 Pomalidomide-amido-C5-PEG2-C6-chlorine 99.69% 否
HY-144085S D-Fructose-6-phosphate-13C6 disodium x.hydrate 99.90% 否
HY-150012S1 N-Lactoyl-Phenylalanine-13C6 98.03% 否
HY-B0451AS1 Dopamine-13C6 hydrochloride 98.71% 否
HY-B0493S1 Niflumic acid-13C6 Inhibitor 99.8% 否
HY-D1574 C6 NBD Sphingomyelin ≥98.0% 否
HY-W018291 Mal-C6-amine TFA 99.73% 否
HY-114118S3 Semaglutide-13C6,15N TFA 96.04% 否
HY-153785 NH2-C6-ARC186 sodium Inhibitor 92.50% 否
HY-D2527 Biotin-PEG4-amide-PEG2-C6-Cl ≥96.0% 否
HY-W017522S1 Adipic acid-13C6 Inhibitor ≥98.0% 否
HY-112618A Thalidomide-O-amido-C6-NH2 TFA Inducer 99.82% 否
HY-148129 Apecotrep Inhibitor 99.62% 否
HY-108971 Demecycline Inhibitor ≥98.0% 否
HY-113296S Indoxyl sulfate-13C6 potassium 98.77% 否
HY-135306 Cl-C6-PEG4-C3-COOH 99.65% 否
HY-143876S L-Argininosuccinic acid-13C6,15N4 barium, dihydrate 95.7% 否
HY-15036S1 Diclofenac-13C6 99.90% 否
HY-161766 L687 Activator / 否
HY-16938S 5'-Methylthioadenosine-13C6 98.45% 否
HY-B0497S1 Niclosamide-13C6 Inhibitor ≥99.0% 否
HY-B1221S1 Flufenamic acid-13C6 99.5% 否
HY-N0216S1 Benzoic acid-13C6 Inhibitor 99.66% 否
HY-P0014S2 Liraglutide-13C6,15N TFA 97.10% 否
HY-W010042S3 L-Glucose-13C6 99.43% 否
HY-W014423S3 L-Histidine-13C6,15N3 hydrochloride hydrate 99.53% 否
HY-W768340 Sucrose-13C6-1 / 否
HY-13948BS Angiotensin II human-13C6,15N TFA 98.11% 否
HY-141939S Triiodothyronine-13C6( hydrochloride) 96.74% 否
HY-159192S SADDNIKTPAE(Arg-13C6,15N4)LLGPLPPSADDNLKT TFA 97.26% 否
HY-18341S2 L-Thyroxine-13C6 91.0% 否
HY-B0190S1 Nafamostat formate salt-13C6 98.11% 否
HY-I0210S 4-Iodoaniline-13C6 / 否
HY-N0098S2 Vanillin-13C6 ≥99.0% 否
HY-N0349S1 Methyl paraben-13C6 Inhibitor 99.90% 否
HY-Y0051S 5-Hydroxymethylfurfural-13C6 Inhibitor ≥98.0% 否
HY-129704A Thalidomide-NH-C6-NH2 TFA Inducer 99.82% 否
HY-130854 Thalidomide-NH-C6-NH-Boc Inducer 96.11% 否
HY-136006A (S,R,S)-AHPC-C6-NH2 hydrochloride / 否
HY-106950S1 Fosfructose-13C6 tetrasodium hydrate 99.90% 否
HY-10715 SSR504734 Inhibitor 99.82% 否
HY-108226S1 Regorafenib N-oxide and N-desmethyl (M5)-13C6 ≥91.0% 否
HY-108372 Boc-C5-O-C5-O-C6-Cl / 否
HY-112499S1 Menaquinone-7-13C6 ≥96.0% 否
HY-112618B Thalidomide-O-amido-C6-NH2 hydrochloride Inducer 99.32% 否
HY-124377 SPDP-C6-NHS ester 98.09% 否
HY-129704B Thalidomide-NH-C6-NH2 hydrochloride Inducer 99.62% 否
HY-130621 OTs-C6-OBn 98.07% 否
HY-131682 3-C6-NBD-cholesterol ≥99.0% 否
HY-131887 Pomalidomide-C6-COOH 98.02% 否
HY-13690S1 Mitotane-13C6 98.62% 否
HY-141887 Thalidomide-O-C6-NHBoc Inducer 95.99% 否
HY-144677 pan-HER-IN-2 98.10% 否
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor 99.62% 否
HY-147622 GLP-1R agonist 9 Agonist / 否
HY-148556 Thalidomide-O-C6-azide Inducer 99.71% 否
HY-173076A HDAC11-IN-1 TFA Inhibitor 99.25% 否
HY-176258S Growth Hormone 22, Arg-13C6,15N4, Lys-13C6,15N2 / 否
HY-23641 NH-bis(C1-Boc) 99.78% 否
HY-90009D (6S,12aR)-Tadalafil Inhibitor 99.34% 否
HY-A0070AS2 Liothyronine-13C6-1 Agonist 98.06% 否
HY-B0150S2 Nicotinamide-13C6 Inhibitor 99.8% 否
HY-B0167S1 Salicylic acid-13C6 ≥97.0% 否
HY-B0975S Penicillin V-13C6 potassium Inhibitor 99.8% 否
HY-B1267S1 Sulfaguanidine-13C6 Inhibitor ≥99.0% 否
HY-B1431S1 Butylparaben-13C6 99.75% 否
HY-D1432 FITC-C6-DEVD-FMK ≥97.0% 否
HY-D1575 C6 NBD Galactosylceramide / 否
HY-D1577 C6 NBD Lactosylceramide ≥98.0% 否
HY-N0304S1 L-DOPA-13C6 ≥98.0% 否
HY-N0384S3 Homovanillic acid-13C6,18O 99.2% 否
HY-N0470S8 L-Lysine-13C6 hydrochloride ≥98.0% 否
HY-N0684S3 Vitamin K1-13C6 ≥99.0% 否
HY-W014225S 3-Phenoxybenzoic acid-13C6 Inducer 99.29% 否
HY-W014375S4 Arginine-13C6,15N4 hydrochloride 95% 否
HY-W017387S2 Sodium α-ketoisocaproic acid-13C6 99.3% 否
HY-W041171S 3-Chloro-L-tyrosine-13C6 97.6% 否
HY-W129359 11β-HSD1-IN-8 ≥95.0% 否
HY-W768336 Gluconate-13C6 sodium / 否
HY-138622S 24:0 Lyso PC-13C6 97.5% 否
HY-148124 6-epi Doxycycline Control 98.47% 否
HY-152039S1 6PPD-Q-13C6 ≥98.0% 否
HY-15550S1 4'-Hydroxy diclofenac-13C6 / 否
HY-159193S DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA 97.61% 否
HY-176034S GPAGPQGP-Arg(13C6,15N4) TFA 99.58% 否
HY-B0035S2 Sulfamethazine-13C6 99.10% 否
HY-B0166S8 L-Ascorbic acid-13C6-1 99.15% 否
HY-B1703S Nifursol-13C6 Inhibitor 99.60% 否
HY-N0771S9 L-Isoleucine-13C6,15N ≥98.0% 否
HY-N7032S1 Uridine 5′-diphosphoglucose-13C6 disodium 98.35% 否
HY-P0090S Calcitonin-13C6,15N4 (salmon) TFA Agonist / 否
HY-P3003S Cereulide-13C6 ≥97.0% 否
HY-W014901S Bisphenol F-13C6 98.32% 否
HY-W103245 Benzo-18-crown-6-ether 99.37% 否
HY-W104010S 2-Chloroaniline hydrochloride-13C6 99.64% 否
HY-W245508 Hexylamine 99.83% 否
HY-W585956 Triclocarban-13C6 99.23% 否
HY-W653962 Triclosan-13C6 99.51% 否
HY-W653994 Ethyl Paraben-13C6 99.65% 否
HY-W654020 Propyl paraben-13C6 99.99% 否
HY-W770434 Octrizole-13C6 ≥97.0% 否
HY-W778225 Vanillic acid-13C6 99.90% 否
HY-W782153 Acetophenone-13C6 98.42% 否
HY-10450S5 Dapagliflozin-13C6-1 Inhibitor / 否
HY-112618 Thalidomide-O-amido-C6-NH2 Inducer / 否
HY-129704 Thalidomide-NH-C6-NH2 Inducer / 否
HY-129974S 3,3'-Diiodo-L-thyronine-13C6 / 否
HY-135250 Thalidomide-4-O-C6-NH2 Inducer / 否
HY-135250A Thalidomide-4-O-C6-NH2 TFA Inducer / 否
HY-136006 (S,R,S)-AHPC-C6-NH2 dihydrochloride / 否
HY-19542S Ceramide C6-d7 Inducer ≥99.0% 否
HY-B0221S Amphotericin B-13C6 Inhibitor / 否
HY-N0683S 2-ambo-Vitamin E-13C6 Inhibitor / 否
HY-W050145S2 Levoglucosan-13C6 / 否
HY-125884 Pomalidomide-amido-C4-amido-C6-NH-Boc / 否
HY-100532S CD437-13C6 Agonist / 否
HY-101064S1 Fmoc-leucine-13C6,15N Modulator / 否
HY-10163S2 Dabigatran-13C6 / 否
HY-10260S2 Vandetanib-13C6 / 否
HY-10450S3 Dapagliflozin-13C6 / 否
HY-10572S1 Efavirenz-13C6 / 否
HY-106950CS3 Fosfructose-6-13C sodium / 否
HY-109120S1 Odevixibat-13C6 Inhibitor / 否
HY-10999S1 Trametinib-13C6 / 否
HY-112586S1 Sulfaethoxypyridazine-13C6 Inhibitor / 否
HY-113251S1 2-Hydroxyestrone-13C6 Inhibitor / 否
HY-113252S1 2-Methoxyestrone-13C6 / 否
HY-113283S Homogentisic acid-13C6 / 否
HY-113407CS D-Fructose-6-phosphate disodium monohydrate-13C6 / 否
HY-114750S Mebendazole-amine-13C6 / 否
HY-114895 SSR504734 free base Inhibitor / 否
HY-115584S Lufenuron-13C6 Inhibitor / 否
HY-116214S1 Cyprodinil-13C6 / 否
HY-116585 C6 D-Threo Ceramide (d18:1/6:0) Activator / 否
HY-116609 C6 L-threo Ceramide Inhibitor / 否
HY-117042 Biotin-PEG2-C6-azide 95.87% 否
HY-117275S1 Meclofenamic acid-13C6 Inhibitor / 否
HY-12008S1 Erlotinib-13C6 hydrochloride / 否
HY-12033S1 2-Methoxyestradiol-13C6 / 否
HY-122062S Fenoxycarb-13C6 / 否
HY-124489S 2-Hydroxyestradiol-13C6 / 否
HY-125296S Fipronil sulfone-13C6 / 否
HY-125888 Boc-NH-C6-amido-C4-acid / 否
HY-126373S1 SN-38 glucuronide-13C6 / 否
HY-12726S Liproxstatin-1-13C6 / 否
HY-12857S Brigatinib-13C6 Inhibitor / 否
HY-128790S1 4-Methoxyestrone-13C6 / 否
HY-129622 NH2-PEG5-C6-Cl / 否
HY-129656 GLP-1 receptor agonist 3 Agonist / 否
HY-13078S Cobimetinib-13C6 racemate Inhibitor / 否
HY-131501S1 Menaquinone-9-13C6 / 否
HY-131622S 7-Aminoclonazepam-13C6 / 否
HY-133685S N-Hexanoyl-L-Homoserine lactone-d3 Modulator / 否
HY-133694S 2-Aminoflubendazole-13C6 / 否
HY-13443S Exendin-4 (Leu-13C6,15N) TFA / 否
HY-13613S Dutasteride-13C6 / 否
HY-136380S Clodinafop-propargyl-13C6 / 否
HY-137912S1 Resveratrol-3-O-beta-D-glucuronide-13C6 / 否
HY-138307 NH2-PEG-Strt (MW 10000) / 否
HY-138308 NH2-PEG-Strt (MW 3000) / 否
HY-138310 Thiol-PEG-COOH (MW 5000) / 否
HY-138311 Boc-NH-PEG-Thiol (MW 10000) / 否
HY-138471 Azido-PEG2-C6-OH / 否
HY-138852 Thalidomide-NH-amido-C6-NH2 Inducer / 否
HY-138852A Thalidomide-NH-amido-C6-NH2 hydrochloride Inducer / 否
HY-139062 C6 Urea Ceramide / 否
HY-141123 SPDP-C6-Gly-Leu-NHS ester / 否
HY-141315 m-PEG6-C6-phosphonic acid ethyl ester / 否
HY-141909S 4-Fluoroiodobenzene-13C6 / 否
HY-141919S 1-Bromo-4-iodobenzene-13C6 / 否
HY-141928S 4-Bromoanisole-13C6 / 否
HY-143276 (S,S,R)-AHPC-C6-NH2 / 否
HY-143276A (S,S,R)-AHPC-C6-NH2 hydrochloride 97.20% 否
HY-143830 t-Boc-N-amido-PEG2-C6-Cl / 否
HY-143843S Isosorbide-2-mononitrate-13C6 / 否
HY-144825 Chol-CTPP Inducer / 否
HY-14520S2 Tetrahydrofolic acid-13C6 / 否
HY-14538S3 Haloperidol-13C6 Antagonist / 否
HY-146002 IDH2R140Q-IN-1 Inhibitor / 否
HY-146687 BuChE-IN-4 Inhibitor / 否
HY-146807 Type II TRK inhibitor 1 Inhibitor / 否
HY-146966S 2-NP-DNSAH-13C6 / 否
HY-146967S 4-(3,6-Dimethylhept-3-yl)phenol-13C6 / 否
HY-146968S Alloerythro-Isoxsuprine-13C6 hydrochloride / 否
HY-146969S Bisdesoxyquinoceton-13C6 / 否
HY-146972S Zearalenone-14-O-β-glucoside-13C6 / 否
HY-147178 C-6 NBD-dihydro-Ceramide / 否
HY-147516 SARS-CoV-2-IN-21 Inhibitor / 否
HY-147551S 3-Iodo-L-thyronine-13C6 / 否
HY-148143 Pomalidomide-C6-NHS ester / 否
HY-148153 C6-Amide-(PEG)n-CH3 / 否
HY-148154 Poly(oxy-1,2-ethanediyl)-propoxy-amide-C6 / 否
HY-148362 Pomalidomide-C6-O-C5-O-C4-COOH 98.55% 否
HY-14894S2 Pragliflozin-13C6 Inhibitor / 否
HY-15027S2 5-Aminosalicylic acid-13C6 / 否
HY-15037S Diclofenac-13C6 sodium heminonahydrate / 否
HY-15037S2 Diclofenac-13C6 sodium / 否
HY-150626 SARS-CoV-2 nsp13-IN-5 Inhibitor / 否
HY-150703S 4-Methoxyestradiol-13C6 / 否
HY-150706S D-fructose-6-phosphate-13C6 / 否
HY-150978 DDAO-C6 / 否
HY-151271 SARS-CoV-2-IN-27 Inhibitor / 否
HY-151271A SARS-CoV-2-IN-27 disodium Inhibitor / 否
HY-151791 (S,R,S)-AHPC-C6-PEG3-butyl-N3 / 否
HY-15284S3 Prasugrel-13C6 Inhibitor / 否
HY-153542 AP-C6 Inhibitor / 否
HY-155141 hCYP3A4-IN-1 Inhibitor / 否
HY-155593 JNK-1-IN-2 Inhibitor / 否
HY-156341S1 LLIYYTSSLHSGVPSR-(Arg-13C6,15N4) (TFA) / 否
HY-156343S1 SNNYATHYAESVK-(Lys-13C6,15N2) (TFA) / 否
HY-156344S1 GLEWVAEIR-(Arg-13C6,15N4) (TFA) / 否
HY-156345S1 LPFTFGQGTK-(Lys-13C6,15N2) (TFA) / 否
HY-158251 BIBD-300 / 否
HY-158383 Pomalidomide-CO-C3-PEG4-C6-NH2 / 否
HY-158803 C6 Biotin glucosylceramide (d18:1/6:0) / 否
HY-158992S SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT TFA / 否
HY-158994S MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA / 否
HY-159017 EM-12-Alkyne-C6-OMs / 否
HY-159018 Alkyne-C6-OMs / 否
HY-161012 RB-07-16 Inhibitor / 否
HY-162295 SARS-CoV-2-IN-83 Inhibitor / 否
HY-162342 Topoisomerase I inhibitor 14 Inhibitor / 否
HY-162370 CYP51-IN-16 Inhibitor / 否
HY-162522 SL-IN-1 Inhibitor / 否
HY-162644 Antitumor agent-170 Inhibitor / 否
HY-162782A V–C6–Bg-PhCl TFA Inhibitor / 否
HY-163422S PHSHPALTPEQK-(Lys-13C6,15N2) / 否
HY-163423S TELAEPTSTR-(Arg-13C6,15N4) / 否
HY-163424S SSVFVADPK-(Lys-13C6,15N2) / 否
HY-163425S AILNYVANK-(Lys-13C6,15N2) / 否
HY-163426S AFFGHYLYEVAR-(Arg-13C6,15N4) / 否
HY-163427S FNLEALVTHTLPFEK-(Lys-13C6,15N2) / 否
HY-163986 Pomalidomide-C2-NHCO-C6 / 否
HY-16561S1 Resveratrol-13C6 / 否
HY-16561S2 (E/Z)-Resveratrol-13C6 / 否
HY-168722 PROTAC PARP1 degrader-3 Degrader / 否
HY-168724 Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH Degrader / 否
HY-168944 ABCB1-IN-4 Inhibitor / 否
HY-169111 SHP2-IN-32 Inhibitor / 否
HY-169292 Antitumor agent-188 / 否
HY-170207S Aurothioglucose 70%-13C6 / 否
HY-170337 N-Me-Thalidomide-NH-C6-NH2 / 否
HY-170448 PROTAC AR Degrader-9 Degrader / 否
HY-170449 E3 ligase Ligand 48 / 否
HY-170818 Grp94 Inhibitor-3 Inhibitor / 否
HY-170926 CQ1373 / 否
HY-171509 Mal-N(Me)-C6-N(Me)-PNU-159682 Inducer / 否
HY-171896 A28-C6B2 / 否
HY-173076 HDAC11-IN-1 Inhibitor / 否
HY-17376S3 Ezetimibe-13C6 / 否
HY-17453S1 Salmeterol-13C6 xinafoate Agonist / 否
HY-17596S Closantel-13C6 Inhibitor / 否
HY-17598S Rafoxanide-13C6 Inhibitor / 否
HY-176167 mTOR ligand 1-C6-amino / 否
HY-176277S Fibrinopeptide B, human-(Val-13C5,15N, Arg-13C6,15N4) TFA / 否
HY-18341S1 Thyroxine hydrochloride-13C6 / 否
HY-18341S3 L-Thyroxine-13C6,15N / 否
HY-18341S4 L-Thyroxine-13C6-1 / 否
HY-18572S 2,4-D-13C6 Inhibitor / 否
HY-19542S1 C6 Ceramide-d11 Inducer / 否
HY-22306S β-D-Glucose pentaacetate-13C6 / 否
HY-34428S 4-Fluorobenzonitrile-13C6 / 否
HY-44630 VH 032 amide-alkylC6-acid / 否
HY-50896S1 Erlotinib-13C6 / 否
HY-66005S3 Acetaminophen-13C6 Inhibitor / 否
HY-66008S2 N-Acetyl mesalazine-13C6 / 否
HY-76929S tert-Butyl 4-aminobenzoate-13C6 / 否
HY-78131S3 Ibuprofen-13C6 / 否
HY-79131S Fmoc-Phe-OH-13C6 / 否
HY-79576S2 Estrone 3-methyl ether-13C6 / 否
HY-A0067S1 Oxybenzone-13C6 / 否
HY-A0130S Sulfalene-13C6 Inhibitor ≥99.0% 否
HY-A0132S12 N-Acetyl-D-glucosamine-13C6 / 否
HY-A0161S Chlophedianol-13C6 / 否
HY-B0141S4 Estradiol-13C6 Agonist / 否
HY-B0141S7 rel-Estradiol-13C6 / 否
HY-B0152S2 Adenine-13C5,15N5 Chemical / 否
HY-B0213S1 Sulfameter-13C6 Inhibitor / 否
HY-B0263S1 Thiabendazole-13C6 Inhibitor / 否
HY-B0273S1 Sulfadiazine-13C6 Inhibitor / 否
HY-B0335S1 Tolfenamic acid-13C6 Inhibitor 99.7% 否
HY-B0337S2 Sulfadimethoxine-13C6 Inhibitor / 否
HY-B0375S1 Argatroban-13C6 hydrochloride Inhibitor / 否
HY-B0467AS Amoxicillin-13C6 Inhibitor / 否
HY-B0497BS Niclosamide-13C6 monohydrate / 否
HY-B0512S1 Sulfamerazine-13C6 Inhibitor / 否
HY-B0574S2 Mefenamic acid-13C6 Inhibitor / 否
HY-B0822S1 Fipronil-13C6 / 否
HY-B0843S Metalaxyl-13C6 Inhibitor 98.4% 否
HY-B0892S3 Benzyl alcohol-13C6 / 否
HY-B0925S Oxacillin-13C6 sodium Inhibitor / 否
HY-B0946S2 Sulfamonomethoxine-13C6 Inhibitor / 否
HY-B0947S1 Sulfanitran-13C6 / 否
HY-B1355AS1 Oxyphenbutazone-13C6 Inhibitor / 否
HY-B1409S Isosorbide dinitrate-13C6 / 否
HY-B1422S 9-Aminoacridine-13C6 Inhibitor / 否
HY-B1436S1 Nifuroxazide-13C6 Inhibitor / 否
HY-B1456AS Fenoprofen-13C6 sodium hydrate / 否
HY-B1779S5 Sucrose-13C6 / 否
HY-B1781S Sulfachloropyridazine-13C6 Inhibitor / 否
HY-B2156S1 Menaquinone-4-13C6 / 否
HY-B2236S1 DL-Lysine-13C6 hydrochloride / 否
HY-B2236S2 DL-Lysine-13C6,15N2 hydrochloride / 否
HY-D1433 FITC-C6-LEHD-FMK / 否
HY-D1573 C6 NBD Phytoceramide / 否
HY-D1749 C6 NBD L-threo-ceramide / 否
HY-E70037 GlcNAc kinase (EcNagK) / 否
HY-E70163 Carbohydrate Sulfotransferase 3 / 否
HY-E70164 Carbohydrate Sulfotransferase 4 / 否
HY-N0086S2 N6-Methyladenosine-13C4 Inhibitor / 否
HY-N0086S3 N6-Methyladenosine-13C3 Inhibitor / 否
HY-N0378S2 D-Mannitol-13C6 ≥98.0% 否
HY-N0379S18 D-Mannose-13C6,d7 / 否
HY-N0455AS4 L-Arginine-13C6,15N4,d7 hydrochloride Activator 96.00% 否
HY-N0470S1 L-Lysine-13C6,15N2,d9 dihydrochloride Inhibitor / 否
HY-N0771S5 L-Isoleucine-13C6,15N,d10 / 否
HY-N0832S1 L-Histidine-13C6,15N3 Inhibitor / 否
HY-N0832S1A L-Histidine-13C6,15N3 hydrochloride / 否
HY-N10192 Aculene D Inhibitor / 否
HY-N11137 3′-Omethyl-5′-hydroxydiplacone Inhibitor / 否
HY-N1127S Tricin-d6 / 否
HY-N12396 Cyclosporin U / 否
HY-N1380S2 Guaiacol-13C6 / 否
HY-N1393S 2-Methoxybenzoic acid-13C6 / 否
HY-N1394S p-Anisic acid-13C6 Inhibitor / 否
HY-N6612S D-Glucuronic acid sodium monohydrate-13C6 / 否
HY-N7092S13 D-Fructose-13C6,d7 / 否
HY-N7106S2 Dimethyl phthalate-13C6,d4 / 否
HY-N7106S3 Dimethyl phthalate-13C6 / 否
HY-N7123S1 Sulfacetamide-13C6 Inhibitor / 否
HY-N7147 Irisquinone / 否
HY-N7464 Jolkinolide E / 否
HY-N7745S2 Glucosylsphingosine-13C6 / 否
HY-N8462 6-O-Nicotinoylscutebarbatine G / 否
HY-N8588 Methyl ganoderate C6 / 否
HY-N9454 Garcinoic acid / 否
HY-P11199S IVLIGNAGVG-(Lys-13C6,15N2) / 否
HY-P2625S GLP-2(3-33) (Leu-13C6,15N) / 否
HY-P2625S1 GLP-2(3-33) (Leu-13C6,15N) TFA Agonist / 否
HY-P4596S H-Gly-Arg-OH (Arg-13C6,15N4) / 否
HY-P4596S1 H-Gly-Arg-OH (Arg-13C6,15N4) TFA / 否
HY-P5168AS GPSVFPLAPSSK-13C6,15N2 TFA Inhibitor / 否
HY-P5190S RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE / 否
HY-P5190S1 RQIK-(Lys-fructosyl)-QTA-(Leu-13C6,15N)-VE TFA / 否
HY-P5201S VTSEGAGLQLQK-13C6,15N2 / 否
HY-P5201S1 VTSEGAGLQLQK-13C6,15N2 TFA / 否
HY-P5628 Termicin / 否
HY-P6421S LGPLVEQG-Arg(13C6,15N4) TFA / 否
HY-P6422S LAVYQAGA-Arg(13C6,15N4) TFA / 否
HY-P6423S CLAVYQAGA-Arg(13C6,15N4) TFA / 否
HY-P6424S LGADMEDVCG-Arg(13C6,15N4) TFA / 否
HY-RS01752 C6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05970 H3C6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS05978 H4C6 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS11297 PSMA7 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-W001138S 4-Bromobenzaldehyde-13C6 / 否
HY-W007318S 2-Iodoaniline-13C6 / 否
HY-W007527S 4-Bromo-2-chlorophenol-13C6 / 否
HY-W008253S3 5-Hydroxyindole-3-acetic acid-13C6 / 否
HY-W008452S H-Tyr(3-I)-OH-13C6 / 否
HY-W008642S (Leu-13C6,15N)-Leu-OH TFA / 否
HY-W009048 Dicyclohexano-18-crown-6-ether / 否
HY-W009300S1 4-Hydroxyestrone-13C6 / 否
HY-W009597S 1,5-Dichloro-2,4-dinitrobenzene-13C6 / 否
HY-W010696AS Reverse T3-13C6 hydrochloride 96% 否
HY-W013186S1 Lansoprazole sulfide-13C6 / 否
HY-W013396S 4-Iodobenzoic Acid-13C6 / 否
HY-W013677S 4-Fluorobenzoic acid-13C6 / 否
HY-W014223S 2,4-Dihydroxybenzophenone-13C6 / 否
HY-W014375S1 Arginine-13C6,15N4,d7 hydrochloride / 否
HY-W014423S2 L-Histidine-13C6 hydrochloride hydrate / 否
HY-W014531S 2,6-Dichloro-4-nitrophenol-13C6 / 否
HY-W014632S 4-Trifluoromethylsalicylic acid-13C6 / 否
HY-W015198S 4-(Trifluoromethyl)benzoic acid-13C6 / 否
HY-W017401S Benzisothiazolinone-13C6 Inhibitor / 否
HY-W017529S 6-Chloro-1,3,5-triazine-2,4-diamine-13C3 / 否
HY-W018386S 3-​Bromo-​L-​tyrosine-13C6 / 否
HY-W069721S1 N-Acetylsulfanilamide-13C6 / 否
HY-W074977S 2,6-Dibromo-4-nitrophenol-13C6 / 否
HY-W092298S Methyl 4-(2-hydroxyethyl)benzoate-13C6,d2 / 否
HY-W100312S o-Toluidine-13C6 hydrochloride / 否
HY-W106014S [1,1'-Biphenyl]-3-amine-13C6 hydrochloride / 否
HY-W156511S Diacetylsulfanilamide-13C6 / 否
HY-W243018S 1,2:5,6-Di-O-isopropylidene-a-D-glucofuranose-1,2,3,4,5,6-13C6 / 否
HY-W269700S Ile-(Leu-13C6,15N)-OH TFA / 否
HY-W278861S Desoxy-Mequindox-13C6 / 否
HY-W280531S DNSAH-13C6 ≥99.0% 否
HY-W344468S Adipate-13C6 sodium / 否
HY-W584531 VH032-C6-NH-Boc / 否
HY-W653738 2,4,5,6-Tetrachlorophenol-13C6 / 否
HY-W653798 Hexachlorobenzene-13C6 / 否
HY-W654109 2-Chloroanthracene-13C6 / 否
HY-W654206 D-Glucose 6-Phosphate Sodium Salt Hydrate-13C6 / 否
HY-W739894S Diclofenac metabolite-13C6 / 否
HY-W747060 Benzyl 4-hydroxybenzoate-13C6 / 否
HY-W747879 Diclofenac Amide-13C6 / 否
HY-W748193 2,5-Furandicarboxylic acid-13C6 / 否
HY-W748418 1-Thio-β-D-glucose Sodium Salt Dihydrate-13C6 / 否
HY-W748540 N6-[(Allylamino]carbonothioyl]lysine-13C6,15N2 / 否
HY-W748541 N6-[(Benzylamino)carbonothioyl]lysine-13C6,15N2 / 否
HY-W748688 N4-Acetylsulfamethoxazole-13C6 / 否
HY-W749012 (2,4,6-Trichlorophenoxy)acetic acid-13C6 / 否
HY-W749198 1,2,4-Trimethyl benzene-13C6 / 否
HY-W749199 2-Ethyl toluene-13C6 / 否
HY-W749377 1,2,3,4,5-Pentabromo-6-methylbenzene-13C6 / 否
HY-W749378 1,2,3,4,5-Pentabromo-6-ethylbenzene-13C6 / 否
HY-W749528 3-Deoxyglucosone-13C6 / 否
HY-W749598 N-Methoxy-N-methylnicotinamide-13C6 / 否
HY-W749645 Acrolein 2,4-Dinitrophenylhydrazone-13C6 / 否
HY-W750212 Acid Orange 7-13C6 / 否
HY-W750294 δ-Hexachlorocyclohexane-13C6 / 否
HY-W750399 4,5,6,7-Tetrabromoisobenzofuran-1,3-dione-13C6 / 否
HY-W750442 4-Bromophenoxytriisopropylsilane-13C6 / 否
HY-W750443 4-Bromophenol-1,2,3,4,5,6-13C6 / 否
HY-W750888 (Z)-Chlorolefin-13C6 / 否
HY-W751179 Midostaurin-13C6 / 否
HY-W751180 3-Hydroxy Midostaurin-13C6 / 否
HY-W751181 O-Desmethyl midostaurin-13C6 / 否
HY-W751444 2,4-Dimethylanisole-13C6 / 否
HY-W751475 1-(Methoxymethoxy)benzene-13C6 / 否
HY-W751526 N4-Acetylsulfamethazine-13C6 / 否
HY-W751537 4-[[(4-Fluorophenyl)imino]methyl]phenol-13C6 / 否
HY-W751834 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione-13C3 / 否
HY-W751917 Aniline-13C6 hydrochloride / 否
HY-W752253 N-2-Naphthalenyl-N-phenyl-2-naphthalenamine-13C6 / 否
HY-W753343 2-Chloro-N-phenylacetamide-13C6 / 否
HY-W753344 2-(2,6-Dichlorophenoxy)-N-phenylacetamide-13C6 / 否
HY-W753345 2,6-Dichlorodiphenylamine-13C6 / 否
HY-W753370 2,4,5-Trichloronitrobenzene-13C6 / 否
HY-W754216 Diacetone-β-D-fructose-13C6 / 否
HY-W754400 Mannosan,95%-13C6 / 否
HY-W754982 N-Cyclohexyl-1,3-benzothiazol-2-amine-13C6 / 否
HY-W755778 3-Iodothyronamine hydrochloride-13C6 / 否
HY-W756637 Ibufenac-13C6 / 否
HY-W766332 7-Hydroxy coumarin glucuronide sodium-13C6 / 否
HY-W766388 2-Amino-2-deoxyglucose hydrochloride-13C6 / 否
HY-W766699 6-Amino-4-hydroxy-2-mercaptopyrimidine-13C / 否
HY-W767285 6-Amino-5-nitrosouracil-13C2 / 否
HY-W768181 1,5-Anhydrosorbitol-13C6 / 否
HY-W768211 2-Deoxy-2-fluoro-D-glucose-13C6 / 否
HY-W768246 Galactose 1-phosphate-13C6 potassium / 否
HY-W768262 D-(+)-Glucono-1,5-lactone-13C6 / 否
HY-W768295 D-Lactose monohydrate-13C6 / 否
HY-W768912 Paclitaxel-13C6 / 否
HY-W768934 L-Gulono-1,4-lactone-13C6 / 否
HY-W769361 5-Hydroxymethyl-2-furancarboxylic acid-13C6 / 否
HY-W770176 2-Benzyl-5-chlorobenzaldehyde-13C6 / 否
HY-W770294 3,4,5,6-Tetrabromophthalic acid-13C6 / 否
HY-W770721 Phenylboronic acid-13C6 / 否
HY-W770952 DL-Phenylmercapturic Acid-13C6 / 否
HY-W771036 Argininic acid-13C6 / 否
HY-W771037 2-Oxoarginine-13C6 / 否
HY-W771072 4-Hydroxybenzenesulfonic Acid-13C6 / 否
HY-W776938 Ethyl nicotinate hydrochloride-13C6 / 否
HY-W777188 6-Hydroxy Chlorzoxazone-13C6 / 否
HY-W777334 2,5-Dioxopyrrolidin-1-yl nicotinate-13C6,d4 / 否
HY-W777393 Umbelliferone-13C6 / 否
HY-W777439 4-Chloro-6-nitrosoresorcinol-13C6 / 否
HY-W777440 4-Chloro resorcinol-13C6 / 否
HY-W777456 Phenanthrene-13C6 / 否
HY-W777457 Anthracene-13C6 / 否
HY-W777458 Fluorene-13C6 / 否
HY-W777477 Homovanillic Acid-13C6 / 否
HY-W777496 Saccharin-13C6 / 否
HY-W777526 Nitisinone-13C6 / 否
HY-W777534 4-Acetamidobenzene-1-sulfonyl chloride-13C6 / 否
HY-W777535S Naphthalene-13C6 / 否
HY-W777546 (5-Formylfuran-2-yl)methyl acetate-13C6 / 否
HY-W777581 4-tert-Octylphenol-diethoxylate-13C6 / 否
HY-W777582 4-tert-Octylphenol monoethoxylate-13C6 / 否
HY-W777823 N-(a,a-Dimethylbenzyl)benzenesulfonamide-13C6 / 否
HY-W777928 Cyclohexane-1,3-dione-13C6 / 否
HY-W778065 N-(tert-Butoxycarbonyl)aniline-13C6 / 否
HY-W778171 2-Benzyloxy-5-nitro-benzoic Acid Benzyl Ester-13C6 / 否
HY-W778172 2-Benzyloxy-3-nitro-benzoic Acid Benzyl Ester-13C6 / 否
HY-W778173 2-Benzyloxy-benzoic Acid Benzyl Ester-13C6 / 否
HY-W778240 2-Naphthoic acid-13C6 / 否
HY-W778242 3,4-Dihydronaphthalen-1-one-13C6 / 否
HY-W778408 Tamoxifen-13C6 / 否
HY-W779969 2-Acetyl-4-tetrahydroxybutyl imidazole-13C6 / 否
HY-W780293 2-Phenylphenol-13C6 / 否
HY-W800777 6-(3-Hydroxypropylamino)hexyl 2-hexyldecanoate / 否
HY-Y0264S 4-Hydroxybenzoic acid-13C6 / 否
HY-Y0589S m-Cyanobenzoic acid-13C6 / 否
HY-Y0721S 3-Bromofluorobenzene-13C6 / 否
HY-Y0931S 3-Iodobenzoic Acid-13C6 / 否
HY-Y1152S Fluorobenzene-13C6 / 否
HY-Y1636S Fmoc-Arg(Pbf)-OH-13C6,15N4 / 否
HY-101277S1 Vadadustat-13C6 Inhibitor / 否
HY-10268S2 Betrixaban-13C6 / 否
HY-10574S1 Rilpivirine-13C6 Inhibitor / 否
HY-113046S1 5-Methyltetrahydrofolic acid-13C6 / 否
HY-114667 Lavendustin C6 Inhibitor / 否
HY-121267S Dicamba-13C6 / 否
HY-12767S2 Carvedilol metabolite 4-Hydroxyphenyl Carvedilol-13C6 / 否
HY-128417S4 alpha-D-glucose-13C6 / 否
HY-128417S5 alpha-D-glucose-13C6,d7 / 否
HY-129503S 2-Heptyl-4-quinolone-13C6 / 否
HY-13017S4 Ivacaftor-13C6 Agonist / 否
HY-132274 DMS(O)MT aminolink C6 / 否
HY-13458S2 Droxidopa-13C6 / 否
HY-13553S1 Anidulafungin-13C6 Inhibitor / 否
HY-137222S 4',5-Dihydroxy Diclofenac-13C6 Inhibitor / 否
HY-137522AS1 Zidovudine Glucuronide-13C6 / 否
HY-13966S3 2-Deoxy-D-glucose-13C6 / 否
HY-14171S2 Bexarotene-13C6 / 否
HY-143679S 4-(3',6'-Dimethyl-3'-heptyl)phenol diethoxylate-13C6 / 否
HY-143704S 5-Aminosalicylic acid-13C6 hydrochloride 99.53% 否
HY-143857S 22:0 Lyso PC-13C6 / 否
HY-14397S3 Indomethacin-13C6 Inhibitor / 否
HY-145517 C6-Phytoceramide Inducer / 否
HY-14740S2 Elvitegravir-13C6 Inhibitor / 否
HY-14832S1 Ataluren-13C6 Inhibitor / 否
HY-149563 Thalidomide-5-O-C6-NH2 hydrochloride / 否
HY-150194S Fructose-glutamic acid-13C6 / 否
HY-150679S Remdesivir-13C6 / 否
HY-151792 Pomalidomid-C6-PEG3-butyl-N3 / 否
HY-15206S2 Glibenclamide-13C6 / 否
HY-15388S2 Tazarotene-13C6 Agonist / 否
HY-15409S1 Empagliflozin-13C6 / 否
HY-158656 3-Keto sphinganine (d6:0) hydrochloride / 否
HY-159077 H2N-C6-NH-CO-CH2-O-Ph-CH2-NH-Boc / 否
HY-161538 Lenalidomide-C6-Br / 否
HY-163992S VTMTRDTSISTAYMELSR-(Ile-13C6,15N) / 否
HY-163993S GMDRWGQGTLVTVSS-(Leu-13C6,15N) / 否
HY-165087 C6 Biotin ceramide (d18:1/6:0) / 否
HY-165975 (2S)-3-Keto sphinganine (d6:0) (hydrochloride) / 否
HY-166282 C6 NBD-L-threo-dihydrosphingosine / 否
HY-16637S5 Folic acid-13C6 / 否
HY-168132 Thalidomide-NH-C-C6H10-C-acid / 否
HY-168291 Thalidomide-NH-CH2-CONH-C6-Br / 否
HY-17007S2 Saquinavir-13C6 / 否
HY-17043S3 Loratadine-13C6 / 否
HY-172361 Thalidomide-F-NH-C6-adize / 否
HY-173085S TPPSSGEPPK-(Lys-13C6,15N2) TFA / 否
HY-173086S TPSLPTPPTR-(Arg-13C6,15N4) TFA / 否
HY-173087S TPPSSGEPPKSGDR-(Arg-13C6,15N4) TFA / 否
HY-173088S IPAK(pT)PPAPK-(Lys-13C6,15N2) TFA / 否
HY-173089S TPSLP(pT)PP(pT)REPK-(Lys-13C6,15N2) TFA / 否
HY-173090S VAVVR(pT)PPK(pS)PSSAK-(Lys-13C6,15N2) TFA / 否
HY-173091S pyroE-QEAVEGGC(Cam)SHLGQSYADR-(Arg-13C6,15N4) TFA / 否
HY-173098S YLPNPA(Leu-13C6,15N)QR TFA / 否
HY-173099S GNSP(Ile-13C6,15N)SQR TFA / 否
HY-173100S GIFP(Leu-13C6,15N)AER TFA / 否
HY-173101S GHFP(Leu-13C6,15N)AER TFA / 否
HY-173104S SLPAS(Leu-13C6,15N)QR TFA / 否
HY-173106S YTASD(Leu-13C6,15N)FR TFA / 否
HY-17356S2 Fenofibrate-13C6 / 否
HY-17359S1 Deferasirox-13C6 Inhibitor / 否
HY-17405S Alarelin-(Leu-13C6,15N) TFA / 否
HY-17430S2 Amprenavir-13C6 Inhibitor / 否
HY-17498S3 Atenolol-13C6 Antagonist / 否
HY-176032S GPAAGPQGP-Arg(13C6,15N4) TFA / 否
HY-176177S DEKM(Leu-13C6,15N)VLWVVALSGISTLFFAA / 否
HY-176178S LFVFAVCFSCWV(Leu-13C6,15N)PQGQYGR / 否
HY-18342S1 Diflunisal-13C6 Inhibitor / 否
HY-19542A N-Hexanoyl-L-erythro-sphingosine / 否
HY-19821S1 Fmoc-Ile-OH-13C6,15N / 否
HY-76520S Sitaxsentan-13C6 Antagonist / 否
HY-78726S2 Fosamprenavir-13C6 Inhibitor / 否
HY-79128S1 Fmoc-L-Lys (Boc)-OH-13C6,15N2 Inhibitor 99.90% 否
HY-B0083S1 Leflunomide-13C6 Inhibitor / 否
HY-B0122S Topiramate-13C6 / 否
HY-B0122SS1 Topiramate-13C6-1 / 否
HY-B0124S2 Zonisamide-13C6 Inhibitor / 否
HY-B0149S2 Tranexamic acid-13C6 / 否
HY-B0152S3 Adenine-13C5 Chemical / 否
HY-B0174AS Olsalazine-13C6 / 否
HY-B0211S1 Riluzole-13C6 Inhibitor / 否
HY-B0227S3 Ketoprofen-13C6 Inhibitor / 否
HY-B0363S1 Nimesulide-13C6 Inhibitor / 否
HY-B0411S2 Domperidone-13C6 Inhibitor / 否
HY-B0482S1 Acemetacin-13C6 Inhibitor / 否
HY-B0580S2 Ketorolac-13C6 / 否
HY-B0637S2 Bezafibrate-13C6 Agonist / 否
HY-B0945S Nitromide-13C6 / 否
HY-B1125S Glucosamine-13C6 / 否
HY-B1190S2 Cefadroxil-13C6 / 否
HY-B1374S2 Florfenicol-13C6 Inhibitor / 否
HY-B1941S1 4-tert-Octylphenol-13C6 / 否
HY-D1576 C6 NBD L-threo-dihydroceramide / 否
HY-N0455AS11 L-Arginine-13C6,d14 hydrochloride / 否
HY-N10004S Fructose-proline-13C6 / 否
HY-N3622 Corchoionoside C / 否
HY-P0119S Lixisenatide (Leu-13C6,15N) TFA / 否
HY-P3207S DLPLTFGGGT-Lys-13C6,15N2 TFA / 否
HY-P5168S GPSVFPLAPSSK-13C6,15N2 Inhibitor / 否
HY-P6425S LCADMEDV-Arg(13C6,15N4) TFA / 否
HY-RS16809 C6 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23249 C6 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W008125S Acetobromo-a-D-glucuronic acid-13C6 methyl ester / 否
HY-W008614S1 Lansoprazole sulfone-13C6 Inhibitor / 否
HY-W010209S DL-Histidine-13C6,15N3 / 否
HY-W011577S1 Dibenzo[a,c]anthracene-13C6 / 否
HY-W012507S1 2,6-Dichlorobenzoic acid-13C6 / 否
HY-W012530S Phenylpyruvic acid-13C6 sodium / 否
HY-W014423S1 L-Histidine-13C6,15N3,d5 hydrochloride hydrate / 否
HY-W016814S (Z)-Aconitic acid-13C6 / 否
HY-W018587S Bis(2-Ethylhexyl)-tetrabromo phthalate-13C6,d34 / 否
HY-W020678S 2-Methylbutanal-13C2 / 否
HY-W024986S 4-(4-Hexoxyphenyl)benzonitrile-13C6 / 否
HY-W050154S Kojic acid-13C6 Inhibitor / 否
HY-W097410S1 2-Iodo-N-phenylacetamide-13C6 / 否
HY-W1008621 GalNAc-THA C6 phosphoramidite / 否
HY-W101298S (Leu-13C6,15N)-Ile-OH TFA / 否
HY-W104549S 3,6-Dichloro-2-hydroxybenzoic acid-13C6 ≥99.0% 否
HY-W140740S Hexabromobenzene-13C6 / 否
HY-W145482S1 3-O-Methyl-D-glucopyranose-13C6 / 否
HY-W245946 Hexyl bromide / 否
HY-W337886S 2-Ethylhexyl 2,3,4,5-tetrabromobenzoate-13C6,d17 / 否
HY-W585890S Benzo[pqr]tetraphen-3-ol-13C6 / 否
HY-W585933S Fructose-alanine-13C6 / 否
HY-W585934S Fructose-phenylalanine-13C6 / 否
HY-W590539 ω-azido-C6 Ceramide Inhibitor / 否
HY-W590666 N-Hexanoyldihydrosphingosine / 否
HY-W591352 Thalidomide-5-(C6-amine) / 否
HY-W591973 OTs-C6-NHBoc / 否
HY-W653832 Phenol-13C6 / 否
HY-W654082 Bisphenol e-13C6 / 否
HY-W715199S Pentabromo benzene-13C6 / 否
HY-W721295S N-(1-Deoxy-D-fructos-1-yl)-L-methionine-13C6 / 否
HY-W738582S N-(1-Deoxy-D-fructos-1-yl)​-L-threonine-13C6 / 否
HY-W746828 Oxindole-3-acetic acid-13C6 / 否
HY-W747703 Hippuric acid-13C6 / 否
HY-W766368 C6 Ceramide-13C2,d2 / 否
HY-W770295 2,3,4,5-Tetrabromobenzoic acid-13C6 / 否
HY-W777418 Isosorbide mononitrate-13C6 Inhibitor / 否
HY-W777533 N-Acetyl sulfadiazine-13C6 / 否
HY-W777583 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 / 否
HY-W777681 Triflusal-13C6 / 否
HY-W777964 Phloroglucinol-13C6 / 否
HY-W779345 Reverse T3-13C6 / 否
HY-W780150 1-Bromobenzene-13C6 / 否
HY-W793608S N-(1-Deoxy-D-fructos-1-yl)-L-asparagine-13C6 / 否
HY-W800740 Nonyl 6-bromohexanoate / 否
HY-W800742 Heptadecan-9-yl 6-bromohexanoate / 否
HY-W800743 Heptyl 6-bromohexanoate / 否
HY-W800829 S-Undecyl 6-bromohexanethioate / 否
HY-Y1027S1 2-Chlorobenzoic acid-13C6 / 否
HY-Y1636S1 Fmoc-Arg(Pbf)-OH-13C6 / 否
HY-111543 AN11251 Inhibitor / 否
HY-101009 Methiothepin maleate Antagonist / 否
HY-111491 Methiothepin Antagonist / 否
HY-111824 VH032-thiol-C6-NH2 / 否
抗体抑制剂 (1)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99832 Cosfroviximab 95.00% 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens C6 NCBI NCBI:729
Canis familiaris C6 NCBI NCBI:479348
Macaca fascicularis C6 NCBI NCBI:102116032
Mus musculus C6 NCBI NCBI:12274
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z